Autonomix Medical, Inc. Income Statement
AMIX|3 years of annual SEC 10-K data (FY2024-FY2026)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 3 fiscal years. All figures from audited SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -5.47 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Revenue | - | $0 | $0 |
| SG&A Expense | - | $9.9M | $1.2M |
| R&D Expense | - | $7.1M | $745.0K |
| Operating Income | - | -$17.0M | -$2.0M |
| Income Tax | - | $0 | $0 |
| Net Income | - | -$16.7M | -$2.0M |
| EPS (Basic) | -$6.46 | -$14.82 | -$0.17 |
| Shares Outstanding | 2.5M | 942.6K | 12.3M |